ERF — Eurofins Scientific SE Cashflow Statement
0.000.00%
Last trade - 00:00
- €11.43bn
- €14.19bn
- €6.51bn
- 86
- 27
- 97
- 83
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 272 | 694 | 1,057 | 780 | 423 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 69.6 | 143 | 227 | 12.2 | 135 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -159 | -143 | -315 | -265 | -204 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 678 | 1,224 | 1,512 | 1,136 | 1,018 |
Capital Expenditures | -425 | -356 | -506 | -660 | -550 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -115 | -170 | -515 | -196 | -131 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -540 | -525 | -1,021 | -856 | -681 |
Financing Cash Flow Items | -462 | -105 | -206 | -503 | -308 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -342 | -48.6 | -910 | -311 | 414 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -201 | 616 | -396 | -31.8 | 738 |